Racial bias in the prescription atypical of antipsychotics? [3]

Psychiatric Services

Volumn 54, Issue 1, 2003, Pages 110-

  Pinninti, Narsimha R ^a   Shaila, Bokkala ^a   Kumar, Geetha ^a  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HEALTH CARE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MINORITY GROUP; PHYSICIAN; PRESCRIPTION; RACE; RACE DIFFERENCE; SCHIZOPHRENIA;

EMPIRICAL APPROACH; HEALTH CARE AND PUBLIC HEALTH; MENTAL HEALTH THERAPIES;

ADOLESCENT; ADULT; AGED; ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PREJUDICE; PRESCRIPTIONS, DRUG; PSYCHOTIC DISORDERS;

EID: 0037218752     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ps.54.1.110     Document Type: Letter

References (5)

1. US Surgeon General: Mental Health: Culture, Race, and Ethnicity: A Supplement to Mental Health: A Report of the Surgeon General. Washington, DC, Department of Health and Human Services, 2001
2. Walkup JT, McAlpine DD, Olfson M, et al: Patients with schizophrenia at risk for excessive antipsychotic dosing. Journal of Clinical Psychiatry 61:344-348, 2000
3. Expert consensus guidelines: Treatment of schizophrenia. Journal of Clinical Psychiatry 60(suppl 1):3-80, 1999
4. Mossman D, Lehrer DS: Conventional and atypical antipsychotics and the evolving standard of care. Psychiatric Services 51:1528-1535, 2000
5. Owen RR, Feng W, Thrush CR, et al: Variations in prescribing practices for novel antipsychotic medications among Veterans Affairs hospitals. Psychiatric Services 52:1523-1525, 2001